NORFOLK, Va., Nov. 7, 2018 /PRNewswire-PRWeb/ -- In just the few yearssince its initial development, EOScu, the copper-infused material that actively kills bacteria*, can now be found in over 50 US healthcare facilities with several more planned in the near future. This progress represents the growing awareness that copper,
EOScu, a preventive biocidal surface, has been proven to lower healthcare associated infections (HAIs) in the largest known clinical trial of copper-infused surfaces and textiles. In other ongoing studies, the self-sanitizing surfaces have also proven to significantly reduce the levels of contamination on surfaces surrounding patients, their caregivers and their families. This evidence sparked an increase in hospitals adding EOScu to their infection prevention "toolbox" and further suggests that many are recognizing the need to close the gap between routine daily cleanings and to do so with an option that doesn't require additional work for their teams.
While the Centers for Disease Control and Prevention (CDC) labels HAIs as "avoidable harm," reporting that over 70% can be prevented, HAIs are still a leading cause of death in the United States. There are financial penalties for hospitals and Medicare and Medicaid will not reimburse for their treatment so eliminating HAIs also saves the facility and the taxpayer significant expense. But there is no greater consequence of HAIs than those endured by patients and their families.
EOS Founder and CEO, Ken Trinder, said, "It has been powerful and encouraging to work with healthcare providers that are committed to patient safety. EOS is privileged to have the rare chance to know that what we are doing every day is helping save lives and make people feel safer. These are just a few of the facilities (below) now protecting patients with EOScu. Ask your local hospital what steps they are taking to help protect their patients from preventable infections. Being informed can make all the difference."
About EOS Surfaces: EOS Surfaces, LLC is a medical technology developer and manufacturer in Norfolk, VA. The company has developed novel and proprietary processes for embedding biocidal, essential metals into different polymers with the purpose of creating self-sanitizing and biocidal therapies for implementation in hospitals as part of their infection prevention protocol. Complimentary to and compatible with all infection prevention processes on the market, EOScu is the only practical intervention that is continuously self-sanitizing without requiring additional human intervention and training. Published clinical trials show statistically significant reductions in infection rates and lower mean bioburden beyond 24 hours. The company also developed Health. Care. | An Educational Blog that serves as a resource platform for patients, physicians and the hospital C-suite. For more info, visit http://www.eoscu.com
*Testing demonstrates effective antibacterial activity against Staphylococcus aureus, Enterobacter aerogenes, Methicillin-Resistant Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.
Subscribe to our Free Newsletters!